• Fri, May 13, 2022

Swayampakula Ramakanth Maintained (XFOR) at Strong Buy with Decreased Target to $8.5 on, May 13th, 2022

Swayampakula Ramakanth of HC Wainwright & Co., Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $11 to $8.5 on, May 13th, 2022.

Swayampakula has made no other calls on XFOR in the last 4 months.



There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Swayampakula's Rating of Hold.



This is the rating of the analyst that currently disagrees with Swayampakula


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $10 on, Tuesday, April 5th, 2022

Like: 👍